Other Equity - Daewoong Pharma (KRX:069620) - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 138 700 KRW -0.93% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Pharma
Other Equity Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Other Equity
â‚©56.1B
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Other Equity
â‚©98.3B
CAGR 3-Years
-15%
CAGR 5-Years
1%
CAGR 10-Years
2%
SK Biopharmaceuticals Co Ltd
KRX:326030
Other Equity
â‚©8B
CAGR 3-Years
58%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Other Equity
-â‚©14.6B
CAGR 3-Years
-21%
CAGR 5-Years
-21%
CAGR 10-Years
-9%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Other Equity
â‚©59B
CAGR 3-Years
165%
CAGR 5-Years
79%
CAGR 10-Years
34%
C
Celltrion Pharm Inc
KOSDAQ:068760
Other Equity
â‚©12.5B
CAGR 3-Years
27%
CAGR 5-Years
26%
CAGR 10-Years
12%

See Also

What is Daewoong Pharma's Other Equity?
Other Equity
56.1B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Other Equity amounts to 56.1B KRW.

What is Daewoong Pharma's Other Equity growth rate?
Other Equity CAGR 3Y
58%

Over the last year, the Other Equity growth was 70%. The average annual Other Equity growth rates for Daewoong Pharma have been 58% over the past three years .

Back to Top